21 Anika Therapeutics, Inc. (NASDAQ:ANIK) is a global joint preservation company specializing in early intervention ...

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid ...

Cheryl Blanchard, president and CEO of Anika Therapeutics (ANIK), commented ... to our OA Pain Management and Regenerative Solutions products. We are confident the steps we have taken this ...

Going forward, our continuing operations will reflect the core products serve Anika's hyaluronic acid future, and key reconciliations to quarter results are provided in the appendix materials of ...

We independently select these products—if you buy from one of our links, we may earn a commission. All prices were accurate ...

This acquisition significantly expands Medacta’s sports medicine offering. In total, Parcus brings more than 400 products ...

The switch to Unanet will allow Anika Systems to more easily manage its financials through efficient reporting and empowering employees to contribute to the company's growth. "One of our company's ...

BEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis Pain Management and Regenerative Solutions space focused on early ...

BEDFORD, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue ...